Organon (OGN) Tax Provisions (2020 - 2026)
Organon (OGN) posted quarterly Tax Provisions of $75.0 million for Q2 2026, down 10.71% year-over-year from $84.0 million in Q2 2025, and up 11.94% on a QoQ basis from $67.0 million in Q1 2026.
Organon (OGN) Tax Provisions (2020 - 2026) Analysis & Trends
Organon has reported Tax Provisions for 7 years, with the latest figure at $75.0 million in Q2 2026.
- Tax Provisions for Q2 2026 came in at $75.0 million, down 10.71% year-over-year; the trailing twelve-month figure through Jun 2026 was $282.0 million (up 929.41% YoY), and the FY2025 annual result was $238.0 million, up 517.54% from the prior year.
- Tax Provisions grew to $75.0 million in Q2 2026, from $67.0 million in the prior quarter.
- Over five years, Tax Provisions peaked at $94.0 million in Q1 2022 and troughed at -$442.0 million in Q4 2023.
- A 5-year average of $11.6 million and a median of $46.5 million in 2022 frame the typical range for Tax Provisions.
- The widest annual swing landed in 2022, when Tax Provisions jumped 783.33%; it then plunged 1400.0% in 2023.
- A 5-year view of Tax Provisions shows it stood at $34.0 million in 2022, then plunged by 1400.0% to -$442.0 million in 2023, then jumped by 104.52% to $20.0 million in 2024, then jumped by 185.0% to $57.0 million in 2025, then soared by 31.58% to $75.0 million in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $75.0 million in Q2 2026, $67.0 million in Q1 2026, and $57.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 1.01 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 291.00 Mn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 393.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 242.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -407.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 266.99 Mn |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn | 75.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75.00 Mn |
| Mar 31, 2026 | 67.00 Mn |
| Dec 31, 2025 | 57.00 Mn |
| Sep 30, 2025 | 83.00 Mn |
| Jun 30, 2025 | 84.00 Mn |
| Mar 31, 2025 | 14.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Sep 30, 2024 | -152.00 Mn |
| Jun 30, 2024 | 40.00 Mn |
| Mar 31, 2024 | 35.00 Mn |
| Dec 31, 2023 | -442.00 Mn |
| Sep 30, 2023 | 22.00 Mn |
| Jun 30, 2023 | 12.00 Mn |
| Mar 31, 2023 | 58.00 Mn |
| Dec 31, 2022 | -204.00 Mn |
| Sep 30, 2022 | 55.00 Mn |
| Jun 30, 2022 | 53.00 Mn |
| Mar 31, 2022 | 94.00 Mn |
| Dec 31, 2021 | 34.00 Mn |
| Sep 30, 2021 | 66.00 Mn |